Advance of mesenchymal stem cells in the treatment of cardiovascular diseases in children
10.3760/cma.j.issn.1673-4408.2020.01.002
- VernacularTitle: 间充质干细胞治疗儿童心血管疾病的研究进展
- Author:
Gengying LIU
1
;
Zhongdong DU
1
Author Information
1. Department of Cardiology, Beijing Children′s Hospital, Capital Medical University, Beijing 100045, China
- Publication Type:Review
- Keywords:
Mesenchymal stem cell;
Cardiovascular disease;
Children
- From:
International Journal of Pediatrics
2020;47(1):5-8
- CountryChina
- Language:Chinese
-
Abstract:
Cardiovascular disease(cardiomyopathy, myocardial infarction, heart failure)seriously endanger child health.Although the incidence in children is not very high, the prognosis is usually poor due to limited treatment options.With the rapid development of stem cell technology and regenerative medicine in recent years, stem cell transplantation has been proved to be able to promote cardiomyocyte regeneration, improve myocardial remodeling and left ventricular ejection fraction(LVEF), so as to alleviate cardiovascular diseases fundamentally.Mesenchymal stem cells(MSCs), a kind of pluripotent adult stem cell with profound self-renewal capacity and multi-directional differentiation potential, have been gradually applied in the treatment of children′s cardiovascular diseases, such as cardiomyopathy, myocardial infarction and end-stage heart failure, and initial success has now been achieved.This review is to summarize the advance of MSCs in the treatment of cardiovascular diseases in children.
